Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever

Horneff, G.; Ruperto, N.; Brunner, H.; Quartier, P.; Constantin, T.; Alexeeva, E.; Kone-Paut, I.; Marzan, K.; Wulffraat, N.; Schneider, R.; Padeh, S.; Chasnyk, V.; Wouters, C.; Deschner, J. Kummerle; Kallinich, T.; Lauwerys, B.; Haddad, E.; Nasonov, E.; Trachana, M.; Vougiouka, O.; Abrams, K.; Leon, K.; Lheritier, K.; Martini, A.; Lovell, D.

doi:https://doi.org/10.1186/1546-0096-13-S1-O83

Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever

DSpace/Manakin Repository

Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever

Horneff, G.; Ruperto, N.; Brunner, H.; Quartier, P.; Constantin, T.; Alexeeva, E.; Kone-Paut, I.; Marzan, K.; Wulffraat, N.; Schneider, R.; Padeh, S.; Chasnyk, V.; Wouters, C.; Deschner, J. Kummerle; Kallinich, T.; Lauwerys, B.; Haddad, E.; Nasonov, E.; Trachana, M.; Vougiouka, O.; Abrams, K.; Leon, K.; Lheritier, K.; Martini, A.; Lovell, D.

(2015) Pediatric Rheumatology, volume 13, issue Suppl. 1

(Abstract)

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Rheumatology, Immunology and Allergy, Pediatrics, Perinatology, and Child Health

DOI: https://doi.org/10.1186/1546-0096-13-S1-O83

ISSN: 1546-0096

Publisher: BioMed Central Ltd.

Note: From 8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases Dresden, Germany. 30 September - 3 October 2015